A B S T R A C T Nine skin biopsies from seven herpes gestationis patients were studied by immunofluorescence (IF) techniques. Basement membrane zone (BMZ) deposition of C3 and properdin was present in all nine skin specimens, while IgG deposition was apparent in only one. With in vitro C3 IF staining, positive BMZ staining (HG factor activity) was noted with all seven of our patients' serum samples tested. By standard indirect IF staining, however, only one of these serum samples contained BMZ antibodies of the IgG type. Two cord serum samples, tested by these same methods, yielded positive in vitro C3 staining (HG factor activity) but negative indirect IF staining (IgG). HG factor activity was found to be stable at 56°C for 30 min and in two of three specimens at 56°C for 1 h. Treatment of the complement source (normal human serum) used in the in vitro C3 staining assay with Mg2-EGTA or use of C2-deficient serum as the complement source inhibited HG factor activity. HG factor blocked the specific staining of the BMZ of normal human skin by labeled bullous pemphigoid antibodies. By sucrose density gradient ultracentrifugation and gel chromatography (Sephadex G-200), HG factor activity eluted with IgGcontaining fractions. The highly purified IgG fraction of two herpes gestationis sera was also positive for HG factor activity. Our studies suggest that HG factor is an IgG antibody that may not be demonstrable by conventional IF methods, but which activates the classical complement pathway.
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INTRODUCTION
Herpes gestationis is an interesting and uncommon vesiculobullous dermatosis of pregnancy and the postpartum period. Characterized histopathologically by subepidermal bulla formation, this disease has long been confused with other subepidermal blistering diseases, including dermatitis herpetiformis, erythema multiforme, and bullous pemphigoid. The etiology of herpes gestationis remains unknown.
Using immunofluorescence (IF)1 techniques, Provost (2) . Other herpes gestationis patients who demonstrate IgG deposition in skin lesions but who lack circulating BMZ antibodies, like some bullous pemphigoid patients, have also recently been described (3, 4) . Using various IF techniques, we wish to report our observations in six cases of herpes gestationis in addition to our previously reported case (2) . IF studies of cord serum samples from two of our patients and our attempts to further characterize the so-called HG factor as IgG, are also presented.
METHODS
Specimens. Blood samples were collected under sterile conditions from patients with active disease, separated, aliquoted, and stored at -70'C until used. All of our patients presented with active blistering lesions characterized histopathologically by subepidermal bulla formation consistent with herpes gestationis. Two cord blood samples, obtained at the time of delivery, were handled similarly. Skin lesions, obtained by punch biopsy, were quick-frozen in liquid nitrogen and were stored at -70'C until used. Normal human skin, obtained from surgical specimens, served as an antigen source for both indirect and in vitro complement IF staining assays. All sections, both lesions and normal human skin, were cut in a cryostat at -30'C and were used unfixed in the various IF staining procedures.
Electrophoresis and immunodiffusion. Immunoelectrophoresis (JEP) was performed according to Scheidegger (5) in 25 mM Veronal buffer in 2% agarose at 10 V/cm for 2-3 h. IEP for components of the complement system were run similarly but with the addition of 10 mM EDTA to the buffer. Slides were developed at 370C and read after 24 and 48 h.
Polyacrylamide gel disc electrophoresis was performed according to Ornstein (6) and Davis (7) Antiserum to human IgG was prepared, assayed, and conjugated with FITC by methods previously reviewed in detail (11, 12) . FITC-labeled antiserum to human IgE was a gift from Dr. Gerald Gleich of the Mayo Clinic.
Rabbit antiserum to Factor B was prepared and assayed by the method of Gotze and Miiller-Eberhard (13) . When this antiserum was tested by IEP, addition of inulin to normal human serum produced a gamma-migrating arc in addition to the single beta-migrating protein arc seen in normal human serum alone. Antiserum to human properdin was made in a goat with properdin isolated and assayed by the method of Pensky et al. (14) . This antiserum demonstrated a single cathodally migrating precipitin arc against purified properdin with IEP, similar to the pattern described by McLean and Michael (15) for aged serum. RP reagent also was prepared by the method of Pensky et al. (14) , but was absorbed twice more with zymosan' so that the RP reagent was completely free of properdin. Antiproperdin antiserum was absorbed with RP to ensure its specificity. Details of the preparation and use of the anti-Factor B and antiproperdin have been published previously in detail (16) .
All antisera were tested for specificity and activity by double immunodiffusion (Ouchterlony) and IEP. Units of antiserum, antibody protein assays, fluorescein-protein ratios, and dilutions at which these conjugated antisera were used conformed to our previous standards (11, 12) .
The globulin fraction of one bullous pemphigoid serum with an anti-BMZ antibody titer Staining procedures. Direct IF staining of herpes gestationis skin lesions with antisera to IgG, IgA, IgM, IgE, and C3 was carried out by established methods (11, 12) . A modified indirect IF method recently outlined (1, 16) was used to test these same lesions for the presence of Clq, Factor B, and properdin. In this procedure, skin sections treated initially with rabbit anti-Clq (diluted 1: 100) and rabbit anti-Factor B (diluted 1: 80) were followed by labeled goat anti-rabbit IgG. Similarly, when goat antiproperdin (diluted 1: 10) was used, labeled rabbit anti-goat IgG was used in the second step of the procedure. Specificity controls for this modified indirect IF test have also recently been reported (16 (17, 18) . Two additional controls, however, the substitution of C2-deficient serum for the normal human serum used as the source of complement and the addition of 15 mM Mg.-ethylene glycol-bis-(,3-aminoethyl ether) -N,N,N',N'-tetraacetic acid (Mg2-EGTA) 6 to the complement source, were added. The C2-deficient serum, a gift from Dr. John Leddy, Rochester, N. Y., was tested alone and after the addition of inulin by IEP with antisera to C3 and Factor B. Conversion of C3 and Factor B was apparent only after the addition of inulin. No hemolytic C2 activity was apparent in this serum.
Blocking Table I . A total of nine skin biopsies was studied from our seven patients. In only one of these skin lesions (the second skin biopsy from case 1) was BMZ deposition of IgG noted, findings reported previously (2) . No immunoglobulins (IgG, IgM, IgA or IgE) were noted to be bound to the BMZ in any of the other skin lesions tested. Only cases 5 through 7 were tested with labeled antiserum to IgE, however.
C3 and properdin deposition, on the other hand, were demonstrable in all nine skin lesion specimens (Fig. 1) , but as noted in Table I and as seen in Fig. 1 , properdin staining was always less intense than C3 staining. These observations, therefore, are similar to those reported previously by Provost and Tomasi (1). Factor B deposition, on the other hand, was not detectable in any of our lesional specimens. Clq deposition was noted in three of the immunoglobulin negative lesions in addition to case 1.
Sera. Table II (Table II) .
Cord sera. Cord serum samples from two of our patients were also tested by the various indirect IF and This case was reported previously (2) . § Not tested.
in vitro complement IF staining methods (Table III) . Both cord serum samples yielded negative indirect IF reactions with labeled antisera to IgG, IgA, IgM, and IgE. Low dilution (1:2 and 1:4) C3 staining activity, however, was apparent with both samples, as with serum samples. Negative Clq and C4 staining reactions were also apparent with both of the samples tested. pemphigoid serum samples (17, 18) , all routine controls (antisera alone, complement plus antiserum, and normal human serum plus complement plus antiserum) yielded negative staining reactions. Bullous pemphigoid serum, used as a positive control, yielded positive BMZ staining reactions with complement and labeled anti-C3. Controls performed with three herpes gestationis sera to characterize HG factor activity further are listed in Table IV . As expected, all three sera yielded positive BMZ reactions (at 1: 2 dilutions) with complement and labeled anti-C3. When the HG sera were heated at 56°C for 30 min and fresh complement was added, the staining was not abolished but the intensity was reduced. Further heating at 56°C for 1 h abolished the staining in serum from case 6, but not cases 1 and 4. As expected, heat inactivation (56°C for 30 min) of both HG sera and the complement source resulted in inhibition of C3 staining.
Addition of EDTA to the HG sera, however, again resulted in blocking of BMZ staining in cases 4 and 6, whereas only the intensity of staining was reduced in case 1. Addition of EDTA to the complement source, with or without adding EDTA to the HG sera, also resulted in inhibition of BMZ staining. Addition of Mgs-EGTA to the complement source also inhibited the positive staining.
Finally, if C2-deficient serum is used as the complement source instead of fresh normal human serum, complete inhibition of the C3 staining was apparent with all three serum samples (Fig. 2B ). This finding, along with the Mg2-EGTA studies, suggests that HG factor must be activating complement via the classical pathway (i.e., via C1, C4, and C2).
In an attempt to delineate the site of deposition of HG factor in the skin, studies with labeled bullous pemphigoid antibodies were performed. Repeated treatment of human skin sections with HG factor almost completely inhibited the staining of the BMZ of skin with labeled bullous pemphigoid antibodies. Similar treatment of human skin sections with normal human serum did not result in inhibition of BMZ staining with this reagent.
Sucrose density gradient and chromatographic studies. The globulin fraction of serum from case 4 (Table II) was subjected to sucrose density-gradient ultracentrifugation and to gel chromatography on Sephadex G-200. By the Mancini technique, IgM was located in early sucrose gradient fractions (fractions 2 and 3), while IgG eluted in later fractions (8 through 12). Hg factor activity eluted in these same later fractions (fractions [9] [10] [11] . This suggests a molecular weight for HG factor similar to that of IgG.
Comparable results were also obtained with this serum on gel filtration. Hg factor activity was found again in the fractions containing IgG after separation on Sephadex G-200. IgG was obtained in highly purified form from the sera of cases 4 and 7 by chromatography on DEAE-Sephadex. By JEP and polyacrylamide gel disc electrophoresis, this IgG, the first peak emerging from the DEAE column, did not contain demonstrable amounts of other proteins. HG factor activity was present in the IgG fractions from these two sera ( Fig. 2A) . One of the positive DEAE-Sephadex fractions did yield a positive BMZ staining reaction with antiserum to IgG, after concentration to half its original volume. But this finding was not consistently reproducible.
DISCUSSION
By IF criteria alone, our previously reported case (case 1 in this report) would appear to have bullous pemphigoid rather than herpes gestationis. BMZ antibodies were present in her serum and IgG and Clq deposition was apparent in her skin lesion, in addition to C3 and properdin. These findings, therefore, could be compatible with a diagnosis of bullous pemphigoid (1, 12, 16) . In addition, her circulating BMZ antibodies will fix Clq and C4 (classical pathway) in addition to C3, as do the BMZ antibodies present in most bullous pemphigoid sera (18) .
Although all of the skin lesions studied had both C3 and properdin deposition, IgG deposition was conspicu- Tables I and II. It also appears that HG factor activates the classical pathway of the complement system, rather than the alternative pathway as suggested earlier (1) . Substitution of C2-deficient serum for fresh normal human serum as the complement source, or addition of Mg2-EGTA to the complement source, resulted in complete inhibition of the positive in vitro C3-staining reactions. The early complement components, therefore, must be required for fixation of C3 by HG factor. In light of our IF studies, however, the amounts of Clq and C4 fixed to the BMZ by HG factor must again be below the limits of resolution of the IF techniques used.
If the above observations are correct and HG factor activates the classical complement pathway rather than the alternative pathway, the consistent finding of properdin in skin lesions must be clarified. Recent reports by Fearon and Austen (20) and Schreiber et al. (21) , however, may help explain this finding. They have reported that C3b, generated by C3 activation, will bind properdin. Conceivably, then, with activation of C3 to C3b by HG factor via the classical pathway, properdin is binding to the BMZ because of the presence of C3b on the complex. This possibility, however, must be investigated further.
Although Hg factor appears to be an IgG antibody, but not demonstrable by IF techniques, its further characterization seems warranted. This antibody, however, may be present in serum but in amounts too low to detect. Perhaps the activity resides in one particular IgG subclass that fixes complement avidly. Possibly additional factors (perhaps related to pregnancy) may be required by HG factor to allow the enhancement of activation of C3. Such factors could be interfering with the C3b inactivator, which could explain the amplification of C3 activation. These and other possibilities will be the subject of future investigations. In any event, our studies would suggest that herpes gestationis is a form of bullous disease in pregnancy mediated by BMZ deposition of complement. Whether herpes gestationis is related to classical bullous pemphigoid, however, also remains to be determined.
